(FF) FutureFuel - Overview
Stock: Chemicals, Biofuels, Biodiesel, Surfactants, Glycerin
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 6.35% |
| Yield on Cost 5y | 3.95% |
| Yield CAGR 5y | -45.60% |
| Payout Consistency | 62.4% |
| Payout Ratio | 68.6% |
| Risk 5d forecast | |
|---|---|
| Volatility | 47.9% |
| Relative Tail Risk | -15.1% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.55 |
| Alpha | -32.74 |
| Character TTM | |
|---|---|
| Beta | 0.502 |
| Beta Downside | 0.663 |
| Drawdowns 3y | |
|---|---|
| Max DD | 51.46% |
| CAGR/Max DD | -0.24 |
Description: FF FutureFuel January 01, 2026
FutureFuel Corp. (NYSE:FF) manufactures and sells a diversified portfolio of chemicals and bio-based fuels in the United States, operating through two distinct segments: Chemicals and Biofuels. The Chemicals segment supplies custom and performance chemicals-including polymer modifiers, glycerin, surfactants, and specialty solvents-to end-markets such as coatings, industrial cleaning, oil & gas, and specialty polymers. The Biofuels segment produces and distributes biodiesel and petrodiesel blends, delivering product via truck, barge, and rail to wholesale and retail customers.
Key recent metrics: FY 2023 revenue reached approximately **$310 million**, with the Biofuels segment contributing roughly **45 %** of total sales; EBITDA margin expanded to **12 %** driven by higher biodiesel blend volumes (≈ 140 million gallons) and improved feedstock cost management. Primary economic drivers include the U.S. Renewable Fuel Standard (RFS) credit market, soybean oil price volatility, and the broader diesel demand cycle, which together influence both product pricing and margin stability. A sector-wide trend worth watching is the accelerating corporate shift toward low-carbon fuel mandates, which could lift demand for biodiesel blends and specialty chemicals that enable greener formulations.
For a deeper dive into FF’s valuation sensitivities and comparable peer analysis, you may find ValueRay’s data platform useful for extending this initial overview.
Piotroski VR‑10 (Strict, 0-10) 0.5
| Net Income: -34.6m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.18 > 0.02 and ΔFCF/TA -38.08 > 1.0 |
| NWC/Revenue: 63.67% < 20% (prev 53.53%; Δ 10.14% < -1%) |
| CFO/TA -0.09 > 3% & CFO -17.9m > Net Income -34.6m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 4.46 > 1.5 & < 3 |
| Outstanding Shares: last quarter (43.8m) vs 12m ago 0.09% < -2% |
| Gross Margin: -17.84% > 18% (prev 0.10%; Δ -1794 % > 0.5%) |
| Asset Turnover: 59.75% > 50% (prev 106.8%; Δ -47.03% > 0%) |
| Interest Coverage Ratio: -154.0 > 6 (EBITDA TTM -24.8m / Interest Expense TTM 222.0k) |
Altman Z'' 0.10
| A: 0.43 (Total Current Assets 112.8m - Total Current Liabilities 25.3m) / Total Assets 203.5m |
| B: -0.18 (Retained Earnings -37.0m / Total Assets 203.5m) |
| C: -0.15 (EBIT TTM -34.2m / Avg Total Assets 230.0m) |
| D: -1.08 (Book Value of Equity -37.0m / Total Liabilities 34.4m) |
| Altman-Z'' Score: 0.10 = B |
Beneish M -3.00
| DSRI: 0.99 (Receivables 7.92m/16.0m, Revenue 137.4m/273.8m) |
| GMI: 1.00 (fallback, negative margins) |
| AQI: 1.81 (AQ_t 0.02 / AQ_t-1 0.01) |
| SGI: 0.50 (Revenue 137.4m / 273.8m) |
| TATA: -0.08 (NI -34.6m - CFO -17.9m) / TA 203.5m) |
| Beneish M-Score: -3.00 (Cap -4..+1) = A |
What is the price of FF shares?
Over the past week, the price has changed by +10.94%, over one month by +14.42%, over three months by -4.50% and over the past year by -22.80%.
Is FF a buy, sell or hold?
What are the forecasts/targets for the FF price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 14 | 283.6% |
| Analysts Target Price | 14 | 283.6% |
| ValueRay Target Price | 3.5 | -3.8% |
FF Fundamental Data Overview February 03, 2026
P/B = 0.8521
Revenue TTM = 137.4m USD
EBIT TTM = -34.2m USD
EBITDA TTM = -24.8m USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = -85.6m USD (from netDebt column, last quarter)
Enterprise Value = 58.6m USD (144.1m + (null Debt) - CCE 85.6m)
Interest Coverage Ratio = -154.0 (Ebit TTM -34.2m / Interest Expense TTM 222.0k)
EV/FCF = -1.59x (Enterprise Value 58.6m / FCF TTM -36.8m)
FCF Yield = -62.84% (FCF TTM -36.8m / Enterprise Value 58.6m)
FCF Margin = -26.78% (FCF TTM -36.8m / Revenue TTM 137.4m)
Net Margin = -25.17% (Net Income TTM -34.6m / Revenue TTM 137.4m)
Gross Margin = -17.84% ((Revenue TTM 137.4m - Cost of Revenue TTM 161.9m) / Revenue TTM)
Gross Margin QoQ = -29.90% (prev -24.58%)
Tobins Q-Ratio = 0.29 (Enterprise Value 58.6m / Total Assets 203.5m)
Interest Expense / Debt = unknown (Interest Expense 126.0k / Debt none)
Taxrate = 4.86% (792.0k / 16.3m)
NOPAT = -32.5m (EBIT -34.2m * (1 - 4.86%)) [loss with tax shield]
Current Ratio = 4.46 (Total Current Assets 112.8m / Total Current Liabilities 25.3m)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = 3.45 (negative EBITDA) (Net Debt -85.6m / EBITDA -24.8m)
Debt / FCF = 2.33 (negative FCF - burning cash) (Net Debt -85.6m / FCF TTM -36.8m)
Total Stockholder Equity = 185.4m (last 4 quarters mean from totalStockholderEquity)
RoA = -15.04% (Net Income -34.6m / Total Assets 203.5m)
RoE = -18.66% (Net Income TTM -34.6m / Total Stockholder Equity 185.4m)
RoCE = -19.19% (EBIT -34.2m / Capital Employed (Total Assets 203.5m - Current Liab 25.3m))
RoIC = -17.55% (negative operating profit) (NOPAT -32.5m / Invested Capital 185.4m)
WACC = 7.76% (E(144.1m)/V(144.1m) * Re(7.76%) + (debt-free company))
Discount Rate = 7.76% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 100.0 | Cagr: 0.04%
Fair Price DCF = unknown (Cash Flow -36.8m)
EPS Correlation: -43.59 | EPS CAGR: -32.59% | SUE: N/A | # QB: 0
Revenue Correlation: -69.08 | Revenue CAGR: -33.88% | SUE: N/A | # QB: 0